Thaçi D, Vender R, de Rie M, Conrad C, Soung J, Strober B, Wang M, Cross N, Deherder D, Gomez NN, Gottlieb AB. Bimekizumab efficacy and safety through three years in patients with moderate to severe plaque psoriasis: Long-term results from the BE SURE randomized controlled trial and the BE BRIGHT open-label extension. J of Skin [Internet]. 2022Nov.16 [cited 2024Sep.20];6(6):s68. Available from: https://dermsquared.com/skin/article/view/1824